Back
CytoMed Therapeutics Stock Price Chart
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
50
GDTC
CytoMed Therapeutics
Last Price:
1.95
Seasonality Move:
-37.85%
7 Day Trial
ALL ACCESS PASS
$
7
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GDTC is experiencing slight selling pressure.
CytoMed Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.31 | Sell |
| 20-day SMA: | 2.44 | Sell |
| 50-day SMA: | 2.01 | Buy |
| 200-day SMA: | 2.05 | Buy |
| 8-day EMA: | 2.27 | Sell |
| 20-day EMA: | 2.3 | Sell |
| 50-day EMA: | 2.13 | Buy |
| 200-day EMA: | 2.23 | Sell |
CytoMed Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 47.02 | Sell |
| Chaikin Money Flow: | -25 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.13 - 2.63) | Sell |
| Bollinger Bands (100): | (1.56 - 2.28) | Buy |
CytoMed Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CytoMed Therapeutics Stock
Is CytoMed Therapeutics Stock a Buy?
- CytoMed Therapeutics share price is 2.17 while GDTC 8-day simple moving average is 2.31, which is a Sell signal.
- The stock price of GDTC is 2.17 while CytoMed Therapeutics 20-day SMA is 2.44, which makes it a Sell.
- CytoMed Therapeutics 50-day simple moving average is 2.01 while GDTC share price is 2.17, making it a Buy technically.
- GDTC stock price is 2.17 and CytoMed Therapeutics 200-day simple moving average is 2.05, creating a Buy signal.
GDTC Technical Analysis vs Fundamental Analysis
Sell
50
CytoMed Therapeutics (GDTC)
is a Sell
Is CytoMed Therapeutics a Buy or a Sell?
-
CytoMed Therapeutics stock is rated a Sell
The current CytoMed Therapeutics [GDTC] share price is $2.17. The Score for GDTC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
CytoMed Therapeutics Stock Info
Market Cap:
25.09M
Price in USD:
2.17
Share Volume:
10.78K
CytoMed Therapeutics 52-Week Range
52-Week High:
5.50
52-Week Low:
1.20
Sell
50
CytoMed Therapeutics (GDTC)
is a Sell
CytoMed Therapeutics Share Price Forecast
-
What is the CytoMed Therapeutics stock price today?
The CytoMed Therapeutics stock price is 2.17 USD today. -
Will GDTC stock go up or go down?
CytoMed Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is CytoMed Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, CytoMed Therapeutics is overvalued.
Is CytoMed Therapeutics Stock a Buy?
- CytoMed Therapeutics share price is 2.17 while GDTC 8-day exponential moving average is 2.27, which is a Sell signal.
- The stock price of GDTC is 2.17 while CytoMed Therapeutics 20-day EMA is 2.30, which makes it a Sell.
- CytoMed Therapeutics 50-day exponential moving average is 2.13 while GDTC share price is 2.17, making it a Buy technically.
- GDTC stock price is 2.17 and CytoMed Therapeutics 200-day simple moving average is 2.23, creating a Sell signal.
Fundamental Analysis of CytoMed Therapeutics
Is CytoMed Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.11 per share, and a decrease next year of $0.02 per share.
Technical Analysis of CytoMed Therapeutics
Should I short CytoMed Therapeutics stock?
- GDTC Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting CytoMed Therapeutics is a Buy
- CytoMed Therapeutics Relative Strength Index (RSI) is 47.02, which suggest CytoMed Therapeutics is oversold
- The Bollinger Bands (25) for CytoMed Therapeutics is (2.13 - 2.63), which suggest CytoMed Therapeutics is a Buy
- The Bollinger Bands (100) for CytoMed Therapeutics is (1.56 - 2.28), which suggest CytoMed Therapeutics is a Buy
* CytoMed Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.